DYRONIB 70MG TABLET
by HETERO HEALTHCARE LTD (ONCOLOGY DIV) · 60 TABLETS · Prescription required
Price: ₹1536.80 (MRP ₹1808.00) · In stock
DYRONIB 70MG TABLET contains DASATINIB 70MG, manufactured by HETERO HEALTHCARE LTD (ONCOLOGY DIV). Buy genuine DYRONIB 70MG TABLET online at MedZoneAI with fast, reliable delivery across India.
About DYRONIB 70MG TABLET
Dyronib 70MG Tablet contains dasatinib 70mg. It blocks the BCR-ABL protein that drives Philadelphia chromosome-positive leukaemia, which is why it is classed as a BCR-ABL tyrosine kinase inhibitor (targeted therapy). Specialists use it for chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia. During treatment expect regular checks such as blood counts and fluid around the lungs (pleural effusion). Made by Hetero; pack size 60 tablets. MRP Rs 1,808 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.
Uses of DYRONIB 70MG TABLET
- Treating chronic myeloid leukemia (CML)
- Treating acute lymphoblastic leukemia (ALL)
Side effects of DYRONIB 70MG TABLET
- Low blood cell counts (risk of bleeding and infection)
- Fluid retention and swelling
- Diarrhea or nausea
- Fatigue and headache
- Musculoskeletal pain
Precautions for DYRONIB 70MG TABLET
- Avoid pregnancy and breastfeeding during treatment
- Regularly monitor blood counts and heart function
- Tell your doctor if you have a history of heart or liver problems
- Inform your doctor of all other medicines you are taking
- Avoid grapefruit and its juice
Disclaimer: This information is for general awareness only and is not a substitute for professional medical advice. Always consult a qualified doctor or pharmacist before using any medicine.